Reducing suffering in animal models and procedures involving seizures, convulsions and epilepsy

Journal of Pharmacological and Toxicological Methods

Volumn 67, Issue 1, 2013, Pages 9-15

  Wolfensohn, Sarah ^a   Hawkins, Penny ^b   Lilley, Elliot ^b   Anthony, Daniel ^c   Chambers, Charles ^d   Lane, Sarah ^e   Lawton, Martin ^f   Robinson, Sally ^g   Voipio, Hanna Marja ^h   Woodhall, Gavin ⁱ  

^a Seventeen Eighty Nine   (United Kingdom)

^b Research Animals Department   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d SCHOOL OF MEDICAL SCIENCES   (United Kingdom)

^e NOVARTIS HORSHAM RESEARCH CENTRE   (United Kingdom)

^f Lawton and Stoakes   (United Kingdom)

^g ASTRAZENECA   (United Kingdom)

^h UNIVERSITY OF OULU   (Finland)

ⁱ ASTON UNIVERSITY   (United Kingdom)

Author keywords

Animal welfare; Convulsions; Epilepsy; Refinement; Seizures; Three Rs

Indexed keywords

ANIMAL CARE; ANIMAL HOUSING; ANIMAL TESTING REDUCTION; ANIMAL TESTING REFINEMENT; ANIMAL TESTING REPLACEMENT; ANIMAL USE; ANIMAL WELLBEING; ARTICLE; BIOETHICS; DISEASE MODEL; EXPERIMENTAL ANIMAL WELFARE; HUMAN; NONHUMAN; SEIZURE, EPILEPSY AND CONVULSION;

ANIMAL HUSBANDRY; ANIMALS; DISEASE MODELS, ANIMAL; EPILEPSY; HUMANS; PAIN; SEIZURES;

ANIMALIA;

EID: 84872959616     PISSN: 10568719     EISSN: 1873488X     Source Type: Journal    
DOI: 10.1016/j.vascn.2012.09.001     Document Type: Article

References (41)

1. Bertram E. The relevance of kindling for human epilepsy. Epilepsia 2007, 48:65-74.
2. Buchhalter J.R. Animal models of inherited epilepsy. Epilepsia 1993, 34:S31-S41.
3. National Research Council Recognition and alleviation of distress in laboratory animals 2008, National Academies Press, Washington, DC.
4. Easter A., Bell M.E., Damewood J.R., Redfern W.S., Valentin J.-P., Winter M.J., et al. Approaches to seizure risk assessment in preclinical drug discovery. Drug Discovery Today 2009, 14:876-884.
5. Engstrom F.L., Woodbury D.M. Seizure susceptibility in DBA and C57 mice: The effects of various convulsants. Epilepsia 1988, 29:389-395.
6. Gaskill B.N., Rohr S.A., Pajor E.A., Lucas J.R., Garner J.P. Some like it hot: Mouse temperature preferences in laboratory housing. Applied Animal Behavioural Science 2009, 116:279-285.
7. Hawkins P. Recognizing and assessing pain, suffering and distress in laboratory animals: A survey of current practice in the UK with recommendations. Laboratory Animals 2002, 36:378-395.
8. Hawkins P., Morton D.B., Bevan R., Heath K., Kirkwood J., Pearce P., et al. Husbandry refinements for rats, mice, dogs and non-human primates used in telemetry procedures. Laboratory Animals 2004, 38:1-10.
9. Hawkins P., Morton D.B., Burman O., Dennison N., Honess P., Jennings M., et al. A guide to defining and implementing protocols for the welfare assessment of laboratory animals: eleventh report of the BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on Refinement. Laboratory Animals 2011, 45:1-13.
10. Hooijmans C.R., Leenaars M., Ritskes-Hoitinga M. A gold standard publication checklist to improve the quality of animal studies, to fully integrate the Three Rs, and to make systematic reviews more feasible. Alternatives To Laboratory Animals 2010, 38:167-182.
11. Hosford D.A., Wang Y. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures. Epilepsia 1997, 38:408-414.
12. ILAR (Institute for Laboratory Animal Resources) Guidance for the description of animal research in scientific publications. National Research Council Institute for Laboratory Animal Research. 2011, The National Academies Press, Washington, DC.
13. Jacobs M.P., Leblanc G.G., Brooks-Kayal A., Jensen F.E., Lowenstein D.H., Noebels J.L., et al. Curing epilepsy: Progress and future directions. Epilepsy & Behavior 2009, 14:438-445.
14. Keating S.C.J., Thomas A.A., Flecknell P.A., Leach M.C. Evaluation of EMLA cream for preventing pain during tattooing of rabbits: Changes in physiological, behavioural and facial expression responses. PLoS One 2012, 7(9):e44437.
15. Kilkenny C., Browne W.J., Cuthill I.C., Emerson M., Altman D.G. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biology 2010, 8(6):e1000412.
16. Langer M., Brandt C., Löscher W. Marked strain and substrain differences in induction of status epilepticus and subsequent development of neurodegeneration, epilepsy, and behavioural alterations in rats strain and substrain differences in an epilepsy model in rats. Epilepsy Research 2011, 96:207-224.
17. Langford D.J., Bailey A.L., Chanda M.L., Clarke S.E., Drummond T.E., Echols S., et al. Coding of facial expressions of pain in the laboratory mouse. Nature Methods 2010, 7(6):447-453.
18. Lloyd M.H., Foden B.W., Wolfensohn S.E. Refinement: Promoting the three Rs in practice. Laboratory Animals 2008, 42:284-293.
19. Löscher Animal models of epilepsy for the development of antiepileptic drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Research 2002, 50:105-123.
20. Löscher Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure 2011, 20:359-368.
21. Mason C.R., Cooper R.M. A permanent change in convulsive threshold in normal and brain-damaged rats with repeated small doses of pentylenetetrazol. Epilepsia 1972, 13:663-674.
22. Meller A., Kasanen I., Ruksenas O., Apanaviciene N., Baturaite Z., Voipio H.M., et al. Refining cage change routines: comparison of cardiovascular responses to three different ways of cage change in rats. Laboratory Animals 2011, 45:167-173.
23. Mora G.N., Bramanti P., Osculati F., Chakir A., Nicolato E., Marzola P., et al. Does pilocarpine-induced epilepsy in adult rats require status epilepticus?. PLoS One 2009, 4(6):e5759.
24. Osborne N., Phillips B., Westwood K. Journal editorial polices as a driver for change-Animal welfare and the Three Rs. Proceedings of the Eleventh FELASA Symposium and the 40th Scand-LAS Symposium 2010, (14-17 June 2010), FELASA, Helsinki, Finland, http://www.felasa.eu.
25. Racine R.J. Modification of seizure activity by electrical stimulation: I. After-discharge threshold. EEG and Clinical Neurophysiology 1972, 32(3):269-279.
26. Racine R.J. Modification of seizure activity by electrical stimulation: II. Motor seizure. EEG and Clinical Neurophysiology 1972, 32(3):281-294.
27. Robinson V., Morton D.B., Anderson D., Carver J.F.A., Francis R.J., Hubrecht R., et al. Refinement and reduction in production of genetically modified mice. Laboratory Animals 2003, 37(Suppl. 1):1-51.
28. Russell W.M.S., Burch R.L. The principles of humane experimental technique 1959, Methuen, London.
29. Sato M., Racine R.J., McIntyre D.C. Kindling: Basic mechanisms and clinical validity. Electroencephalography and Clinical Neurophysiology 1990, 76:459-472.
30. Sloviter R.S. The neurobiology of temporal lobe epilepsy: Too much information, not enough knowledge. Comptes Rendus Biologies 2005, 328:143-153.
31. Smith L.S., Austin J., Baker S., Borisyuk R., Eglen S., Feng J., et al. The CARMEN e-Science pilot project: Neuroinformatics work packages. Proceedings of the UK e-Science All Hands Meeting 2007, 591-598.
32. Sotocinal S.G., Sorge R.E., Zaloum A., Tuttle A.H., Martin L.J., Wieskopf J.S., et al. The Rat grimace scale: A partially automated method for quantifying pain in the laboratory rat via facial expressions. Molecular Pain 2011, 7:55-64.
33. Stables J.P., Bertram E.H., White H.S., Coulter D.A., Dichter M.A., Jacobs M.P., et al. Models for epilepsy and epileptogenesis: Report from the NIH workshop, Bethesda, Maryland. Epilepsia 2002, 43(11):1410-1420.
34. Terry J.B., Parzernik T.L., Nelson S.R. Effect of LiCl pretreatment on cholinomimetic-induced seizures and seizure-induced brain edema in rats. Neuroscience Letters 1990, 114:123-127.
35. Tetz L.M., Rezk P.E., Ratcliffe R.H., Gordon R.K., Steele K.E., Nambiar M.P. Development of a rat pilocarpine model of seizure/status epilepticus that mimics chemical warfare nerve agent exposure. Toxicology and Industrial Health 2006, 22:255-266.
36. Turski W.A., Cavalheiro E.A., Schwarz M., Czuczwar S.J., Kleinrok Z., Turski L. Limbic seizures produced by pilocarpine in rats: Behavioural, electroencephalographic and neuropathological study. Behavioural Brain Research 1983, 9:315-335.
37. Van Loo P.L., Kuin N., Sommer R., Avsaroglu H., Pham T., Baumans V. Impact of 'living apart together' on postoperative recovery of mice compared with social and individual housing. Laboratory Animals 2007, 41:441-455.
38. Wells D.J., Playle L.C., Enser W.E., Flecknell P.A., Gardiner M.A., Holland J., et al. Assessing the welfare of genetically altered mice. Laboratory Animals 2006, 40(2):111-114.
39. Wendt H., Soerensen J., Wotjak C.T., Potschka H. Targeting the endocannabinoid system in the amygdale kindling model of temporal lobe epilepsy in mice. Epilepsia 2011, 52:e62-e65.
40. Wolfensohn S., Anderson D. Lifetime experience and cumulative suffering: A report on assessment of lifetime experience and cumulative severity under EU Directive 2010/63 2012, LASA Forum Summer issue.
41. World Health Organisation Atlas: Epilepsy care in the world http://www.who.int/mental_health/neurology/epilepsy_atlas_introdion.pdf.